Analyst Ratings for Regenxbio Inc. (RGNX)
RGNX Rating Summary
RGNX Price Target Summary
- Highest: $45.00 (Clear Street)
- Lowest: $10.00 (Goldman Sachs)
- Average: $24.45
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$24.45 (+213.5%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$24.45 (+213.5%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays » Updated 5/15/2026 |
Eliana Merle | New Coverage | Overweight (N/A) |
12.00 (37.00) |
13.85 (7.80) |
-43.68% | Details |
| 4/1/2025 | Clear Street » Updated 3/5/2026 |
Bill Maughan | New Coverage | Buy (N/A) |
45.00 (N/A) |
7.83 (7.80) |
-0.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
